p21CIP1, humain étiqueté GST, recombinant, exprimé en E. coli ,> = 70 % ( SDS- PAGE), solution de glycérol aqueuse tamponnée

Code: srp5108-50ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

CIP 1 (Cyclin-Dependent Kinase Inhibitor 1A) regulates cell cycle progression, terminal differentiation, and apoptosis. CIP1 was shown to be induced by p5...


en savoir plus

Votre prix
$380.68 50UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

CIP 1 (Cyclin-Dependent Kinase Inhibitor 1A) regulates cell cycle progression, terminal differentiation, and apoptosis. CIP1 was shown to be induced by p53 and to be a potent inhibitor of cyclin-dependent kinase (CDK) activity. DNA damage leads to increased expression of CIP1 in cyclin E-containing complexes and to an associated decrease in cyclin-dependent kinase activity. CIP1 is a critical downstream effector in the p53-specific pathway of growth control in mammalian cells.

Physical form

Supplied in 50mM Tris-HCl, pH 7.5, 150mM NaCl, 10mM glutathione, 0.1mM EDTA, 0.25mM DTT, 0.1mM PMSF, 25% glycerol.

Preparation Note

after opening, aliquot into smaller quantities and store at -70 °C. Avoid repeating handling and multiple freeze/thaw cycles

application(s)cell analysis
assay≥70% (SDS-PAGE)
biological sourcehuman
formbuffered aqueous glycerol solution
Gene Informationhuman ... CDKN1A(1026)
mol wt~46 kDa
NCBI accession no.NM_000389
recombinantexpressed in E. coli
shipped indry ice
storage temp.−70°C
Ce produit répond aux critères suivants: